OMERACT 7 psoriatic arthritis workshop: synopsis

被引:22
作者
Gladman, DD
Strand, V
Mease, PJ
Antoni, C
Nash, P
Kavanaugh, A
机构
[1] Univ Toronto, Toronto Western Hosp, Toronto Western Res InstPsoriat Arthrit Program, Univ Hlth Network,Ctr Prognosis Studies Rheumat D, Toronto, ON M5T 2S8, Canada
[2] Stanford Univ, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Seattle Rheumatol Associates, Seattle, WA USA
[5] Swedish Med Ctr, Rheumatol Clin Res, Seattle, WA USA
[6] Univ Erlangen Nurnberg, Dept Med 3, Erlangen, Germany
[7] Nambour Hosp, Rheumatol Res Unit, Sunshine Coast, Australia
[8] Univ Queensland, Dept Med, St Lucia, Qld 4067, Australia
[9] Univ Calif San Diego, Ctr Innovat Therapy, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA
关键词
D O I
10.1136/ard.2004.032615
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Outcome Measures in Rheumatology (OMERACT) conferences have developed a process by which outcome measures to be included in clinical trials are identified by consensus. During OMERACT 7, held in Asilomar, CA, USA, in May 2004, a workshop on outcome measures in psoriatic arthritis was held. Information derived through a previous Delphi exercise and nominal group process was shared with the participants, as were the results from a study using completed clinical trials with biological therapies. On the basis of the evidence presented and discussions in breakout groups at the OMERACT conference, a set of domains to be included in clinical trials in psoriatic arthritis was developed and a research agenda for further studies in psoriatic arthritis proposed.
引用
收藏
页码:115 / 116
页数:2
相关论文
共 11 条
[1]
Boers M, 1998, J RHEUMATOL, V25, P198
[2]
BOERS M, 1995, J RHEUMATOL, V22, P980
[3]
BOMBARDIER C, 1982, J RHEUMATOL, V9, P753
[4]
[5]
Assessment of patients with psoriatic arthritis - A review of currently available measures [J].
Gladman, DD ;
Helliwell, P ;
Mease, PJ ;
Nash, P ;
Ritchlin, C ;
Taylor, W .
ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :24-35
[6]
GLADMAN DD, IN PRESS J RHEUMATOL
[7]
Lassere MND, 1999, J RHEUMATOL, V26, P459
[8]
*OMERACT 3, 1997, J RHEUMATOL, V24, P763
[9]
Saag KG, 2003, J RHEUMATOL, V30, P639